MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing
J15 · Effective Apr 17, 2022
18 active Medicare policies list R30.0, and 3 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J15 · Effective Apr 17, 2022
JE · Effective Apr 17, 2022
JF · Effective Apr 17, 2022
JJ · Effective Apr 17, 2022
JM · Effective Apr 17, 2022
J5 · Effective Apr 17, 2022
J8 · Effective Apr 17, 2022
J15 · Effective Oct 1, 2015
3 policies from 3 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of R30.0 |
|---|---|---|
| Polymerase Chain Reaction Testing: Selected Indications | Feb 9, 2024 | Covered |
| Policy | Effective | Status of R30.0 |
|---|---|---|
| Outpatient Urine Culture | Jan 6, 2026 | Covered |
| Policy | Effective | Status of R30.0 |
|---|---|---|
| Transvaginal Ultrasound, Non-Obstetrical | Mar 15, 2026 | Not covered |
J15 · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
National · Effective Aug 6, 2026
National · Effective Aug 6, 2026
National · Effective May 14, 2026
J5 · Effective Aug 6, 2026
National · Effective Mar 26, 2026
National · Effective Oct 2, 2025
J6 · Effective Apr 1, 2026